POWERBANK CORP (SUUN) Fundamental Analysis & Valuation

NASDAQ:SUUN • CA73933V1004

Current stock price

0.6394 USD
+0.04 (+7.43%)
At close:
0.6499 USD
+0.01 (+1.64%)
After Hours:

This SUUN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. SUUN Profitability Analysis

1.1 Basic Checks

  • SUUN had negative earnings in the past year.
  • In the past year SUUN has reported a negative cash flow from operations.
  • SUUN had negative earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: SUUN reported negative operating cash flow in multiple years.
SUUN Yearly Net Income VS EBIT VS OCF VS FCFSUUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 -10M -20M -30M

1.2 Ratios

  • SUUN has a worse Return On Assets (-28.36%) than 89.29% of its industry peers.
  • Looking at the Return On Equity, with a value of -154.70%, SUUN is doing worse than 89.29% of the companies in the same industry.
Industry RankSector Rank
ROA -28.36%
ROE -154.7%
ROIC N/A
ROA(3y)-7.44%
ROA(5y)-5.13%
ROE(3y)-56.29%
ROE(5y)-35.21%
ROIC(3y)N/A
ROIC(5y)N/A
SUUN Yearly ROA, ROE, ROICSUUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 0 -50 -100 -150

1.3 Margins

  • SUUN has a better Gross Margin (29.19%) than 80.36% of its industry peers.
  • SUUN's Gross Margin has improved in the last couple of years.
  • SUUN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.49%
GM growth 5YN/A
SUUN Yearly Profit, Operating, Gross MarginsSUUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 0 20 -20 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. SUUN Health Analysis

2.1 Basic Checks

  • SUUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, SUUN has more shares outstanding
  • The debt/assets ratio for SUUN is higher compared to a year ago.
SUUN Yearly Shares OutstandingSUUN Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 10M 20M 30M
SUUN Yearly Total Debt VS Total AssetsSUUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • Based on the Altman-Z score of -0.13, we must say that SUUN is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of SUUN (-0.13) is worse than 87.50% of its industry peers.
  • SUUN has a Debt/Equity ratio of 2.68. This is a high value indicating a heavy dependency on external financing.
  • SUUN's Debt to Equity ratio of 2.68 is on the low side compared to the rest of the industry. SUUN is outperformed by 82.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.68
Debt/FCF N/A
Altman-Z -0.13
ROIC/WACCN/A
WACC9.42%
SUUN Yearly LT Debt VS Equity VS FCFSUUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 20M -20M 40M 60M

2.3 Liquidity

  • SUUN has a Current Ratio of 1.14. This is a normal value and indicates that SUUN is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.14, SUUN perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
  • A Quick Ratio of 0.76 indicates that SUUN may have some problems paying its short term obligations.
  • SUUN has a Quick ratio of 0.76. This is amonst the worse of the industry: SUUN underperforms 83.93% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.76
SUUN Yearly Current Assets VS Current LiabilitesSUUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. SUUN Growth Analysis

3.1 Past

  • SUUN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -337.74%.
  • Looking at the last year, SUUN shows a very negative growth in Revenue. The Revenue has decreased by -16.24% in the last year.
  • The Revenue has been growing by 59.70% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-337.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-240%
Revenue 1Y (TTM)-16.24%
Revenue growth 3Y59.7%
Revenue growth 5YN/A
Sales Q2Q%-81.53%

3.2 Future

  • Based on estimates for the next years, SUUN will show a very strong growth in Earnings Per Share. The EPS will grow by 34.97% on average per year.
  • The Revenue is expected to grow by 7.01% on average over the next years.
EPS Next Y92.42%
EPS Next 2Y51.04%
EPS Next 3Y34.97%
EPS Next 5YN/A
Revenue Next Year61.53%
Revenue Next 2Y28.2%
Revenue Next 3Y7.01%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SUUN Yearly Revenue VS EstimatesSUUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M 80M
SUUN Yearly EPS VS EstimatesSUUN Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 0 -0.1 -0.2

More info and screens

Find the best growth stocksShow best growing peers

4

4. SUUN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SUUN. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 15.67, the valuation of SUUN can be described as correct.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of SUUN indicates a rather cheap valuation: SUUN is cheaper than 92.86% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.79, SUUN is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 15.67
SUUN Price Earnings VS Forward Price EarningsSUUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SUUN Per share dataSUUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as SUUN's earnings are expected to grow with 34.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y51.04%
EPS Next 3Y34.97%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SUUN Dividend Analysis

5.1 Amount

  • No dividends for SUUN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SUUN Fundamentals: All Metrics, Ratios and Statistics

POWERBANK CORP

NASDAQ:SUUN (3/25/2026, 8:00:01 PM)

After market: 0.6499 +0.01 (+1.64%)

0.6394

+0.04 (+7.43%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)02-12
Earnings (Next)05-13
Inst Owners1.2%
Inst Owner Change168.46%
Ins Owners2.73%
Ins Owner ChangeN/A
Market Cap29.78M
Revenue(TTM)43.68M
Net Income(TTM)-37.67M
Analysts44
Price Target2.85 (345.73%)
Short Float %2.44%
Short Ratio0.57
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-310.46%
Min EPS beat(2)-780.9%
Max EPS beat(2)159.98%
EPS beat(4)2
Avg EPS beat(4)-496.03%
Min EPS beat(4)-1523.17%
Max EPS beat(4)159.98%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-46.77%
Min Revenue beat(2)-87.2%
Max Revenue beat(2)-6.34%
Revenue beat(4)0
Avg Revenue beat(4)-33.13%
Min Revenue beat(4)-87.2%
Max Revenue beat(4)-6.34%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.98%
PT rev (3m)-4.8%
EPS NQ rev (1m)11.32%
EPS NQ rev (3m)11.32%
EPS NY rev (1m)-389.86%
EPS NY rev (3m)-389.86%
Revenue NQ rev (1m)-26.74%
Revenue NQ rev (3m)-26.74%
Revenue NY rev (1m)-6.58%
Revenue NY rev (3m)-6.58%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 15.67
P/S 0.94
P/FCF N/A
P/OCF N/A
P/B 1.69
P/tB 13.59
EV/EBITDA N/A
EPS(TTM)-0.13
EYN/A
EPS(NY)0.04
Fwd EY6.38%
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS0.68
BVpS0.38
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -28.36%
ROE -154.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.19%
FCFM N/A
ROA(3y)-7.44%
ROA(5y)-5.13%
ROE(3y)-56.29%
ROE(5y)-35.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.49%
GM growth 5YN/A
F-Score4
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 2.68
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 80.18%
Cap/Sales 8.85%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.76
Altman-Z -0.13
F-Score4
WACC9.42%
ROIC/WACCN/A
Cap/Depr(3y)1443.39%
Cap/Depr(5y)881.44%
Cap/Sales(3y)13.07%
Cap/Sales(5y)7.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-337.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-240%
EPS Next Y92.42%
EPS Next 2Y51.04%
EPS Next 3Y34.97%
EPS Next 5YN/A
Revenue 1Y (TTM)-16.24%
Revenue growth 3Y59.7%
Revenue growth 5YN/A
Sales Q2Q%-81.53%
Revenue Next Year61.53%
Revenue Next 2Y28.2%
Revenue Next 3Y7.01%
Revenue Next 5YN/A
EBIT growth 1Y-1063.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year154.26%
EBIT Next 3Y62.74%
EBIT Next 5YN/A
FCF growth 1Y-182.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-147.13%
OCF growth 3YN/A
OCF growth 5YN/A

POWERBANK CORP / SUUN Fundamental Analysis FAQ

What is the fundamental rating for SUUN stock?

ChartMill assigns a fundamental rating of 2 / 10 to SUUN.


What is the valuation status for SUUN stock?

ChartMill assigns a valuation rating of 4 / 10 to POWERBANK CORP (SUUN). This can be considered as Fairly Valued.


What is the profitability of SUUN stock?

POWERBANK CORP (SUUN) has a profitability rating of 2 / 10.


Can you provide the financial health for SUUN stock?

The financial health rating of POWERBANK CORP (SUUN) is 1 / 10.